Pakistan vs Turkey: Cause of death, by non-communicable diseases, ages 15-59, male
Pakistan
51.7%
in 2021
Turkey
52.4%
in 2021
Pakistan rank
86th
Turkey rank
84th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Pakistan
- Turkey
How they compare
Turkey currently reports 52.4% against 51.7% in Pakistan, a difference of 0.7%.
Across all 6 years both countries report, Turkey has been ahead every year.
Pakistan ranks 86th and Turkey ranks 84th of 185 countries.
Turkey has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pakistan | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 58.5% | 74.4% | 15.8% | Turkey |
| 2010s | 59.3% | 75.4% | 16.1% | Turkey |
| 2020s | 52.5% | 56.4% | 3.9% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Pakistan or Turkey?
- Turkey, at 52.4% against 51.7% in Pakistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Pakistan and Turkey?
- 0.7%, with Turkey ahead.
- How many years of comparable data are there for Pakistan and Turkey?
- 6 years are reported by both, from 2000 to 2021.
- How do Pakistan and Turkey rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Pakistan ranks 86th and Turkey ranks 84th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.